what is gip/glp-1 The activity of GLP-1 and GIP for Type 2 Diabetes and Obesity Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP)

Manufacturers have ramped up production to avoid the shortages previously seen with injectable GLP-1s, aiming for a consistent supply chain for this new oral option

Mol Metab 6:503511

[DOI] [PMC free article] [PubMed] [Google Scholar] 14.Chen L., Magliano D.J., Zimmet P.Z

doi: 10.3389/fphar.2025.1653808 Received 25 June 2025 Accepted 24 September 2025 Published 30 October 2025 Volume 16 - 2025 Edited by Dmaris Silveira, University of Brasilia, Brazil Reviewed by Emine Okumus, Van Yuzuncu Yil University, Trkiye Oswaldo Hernndez-Abreu, Universidad Juarez Autonoma de Tabasco Division Academia de Ciencias Basicas, Mexico Updates Copyright 2025 Diniz, Barros, Silva, Arruda, Claudino, Melo, Sousa Filho, Lacerda Jnior, Soares, Sousa, Ferreira and Silva